 |
|
Trichoblastic Carcinoma Arising from a Nevus Sebaceous
Jin-Tae Kim, Soo-Hyang Lee, Pil-Dong Cho, Hyun-Woo Shin, Han-Seong Kim
Arch Plast Surg. 2016;43(3):297-299. Published online 2016 May 18 DOI: https://doi.org/10.5999/aps.2016.43.3.297
|
|
Citations to this article as recorded by
 Safety and efficacy of the anti-PD1 immunotherapy with nivolumab in trichoblastic carcinomas
E. Toulemonde, S. Chevret, M. Battistella, E. M. Neidhardt, C. Nardin, F. Le Du, N. Meyer, M. Véron, L. Gambotti, A. Lamrani-Ghaouti, P. Jamme, C. Chaffaut, M. De Pontville, E. Saada-Bouzid, M. Beylot-Barry, C. Simon, T. Jouary, A. Marabelle, L. Mortier
Cancer Immunology, Immunotherapy.2023; 72(8): 2649. CrossRef Trichoblastic carcinoma: a comprehensive review of the literature
Michelle A. Boettler, Kathryn T. Shahwan, Nadia Y. Abidi, David R. Carr
Archives of Dermatological Research.2022; 314(5): 399. CrossRef De l’intérêt de différencier les carcinomes trichoblastiques (CT) des carcinomes basocellulaires (CBC). À propos de 21 cas
M. Thomas, C. Bruant-Rodier, F. Bodin, B. Cribier, M. Huther, C. Dissaux
Annales de Chirurgie Plastique Esthétique.2017; 62(3): 212. CrossRef
|